Nilsson Stefan 4

4 · Envista Holdings Corp · Filed Feb 27, 2026

AI-generated summary of this filing

Updated Feb 28, 2026

Envista (NVST) President Stefan Nilsson Receives Stock Awards

What Happened

Stefan Nilsson, President of Nobel Biocare and an officer of Envista Holdings Corp (NVST), was granted equity awards and had a small number of shares withheld to cover tax obligations. On Feb 25, 2026 he was awarded a total of 39,470 award-equivalent shares (7,605 RSUs, 13,845 performance share units at target, and 18,020 option-linked units per footnotes) and 182 shares of common stock were withheld to satisfy tax withholding, resulting in proceeds of $5,385 from that withholding. The awards were granted at $0 per share (typical for RSU/PSU/option grants); the 182-share disposition is a routine tax-withholding sale (a form of sale/disposition).

Key Details

Transaction date: Feb 25, 2026; Form 4 filed Feb 27, 2026 (filing appears timely).
Withheld sale: 182 shares at $29.59 = $5,385 (tax withholding to satisfy withholding obligations).
Grants/awards: 7,605 RSUs; 13,845 PSUs (reported at target; payout could range 0–200% depending on performance); 18,020 option-linked awards — all reported as acquired at $0.
Vesting/conditions (from footnotes): RSUs vest ratably over 3 years; PSUs vest based on 3‑year performance measures (payable 0–200%); the option-like award vests ratably over 3 years.
Shares owned after the transactions: not specified in the provided filing.
Transaction code: F indicates shares withheld for tax obligations; A indicates grant/award. No 10b5‑1 or late filing flag noted.

Context

The tax-related sale of 182 shares is a routine cashless withholding to cover taxes on vesting—not a discretionary open-market sale. The larger items are grants/awards that vest over time (some contingent on performance) and do not represent an immediate purchase or sale of open-market shares. These awards signal compensation rather than an immediate trading view by the insider.

Form 4

Period: 2026-02-25

President, Nobel Biocare

Transactions

Tax Payment
Common Stock
[F1]
2026-02-25$29.59/sh−182$5,385→ 54,759 total
Award
Common Stock
[F2]
2026-02-25+7,605→ 62,364 total
Award
Performance Share Unit
[F3]
2026-02-25+13,845→ 13,845 total
→ Common Stock (13,845 underlying)
Award
Employee Stock Option (Right to Buy)
[F4]
2026-02-25+18,020→ 18,020 total
Exercise: $29.59Exp: 2036-02-25→ Common Stock (18,020 underlying)

Footnotes (4)

[F1]Represents shares of the Issuer's common stock withheld to satisfy tax withholding obligations applicable to the vesting of stock-settled Restricted Stock Units ("RSU").
[F2]Consists of RSUs that will vest ratably on each anniversary of the date of grant over three years, subject to continued service through each such date. Each RSU will convert on a 1-for-1 basis, in shares of the Issuer's common stock.
[F3]Consists of Performance Share Units that will vest, if at all, based on certification of achievement of identified performance measures over a three-year performance period. The amount reported represents the amount of shares payable at target performance; the Reporting Person could earn 0%-200% of the amount reported depending on the level of performance achieved.
[F4]This Option will vest ratably on each anniversary of the date of grant over three years, subject to continued service through each such date.

Signature

/s/ Heather Turner, By POA from Stefan Nilsson|2026-02-27

1 file